|1||Enrolling by invitation||
Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212
|2||Active, not recruiting||
Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
Arikayce for Nontuberculous Mycobacteria
† Study has passed its completion date and status has not been verified in more than two years.